Largest biotechnology: pharmaceutical preparations companies
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$4.938 T
5.0% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$9.876 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.10T | $1,169.60 | -1.61% | United States |
| 2 | Johnson & JohnsonJNJ | $618.1B | $256.48 | -0.76% | United States |
| 3 | AbbVieABBV | $481.4B | $272.42 | +0.39% | United States |
| 4 | Merck & Co.MRK | $351.3B | $142.38 | -0.29% | United States |
| 5 | NovartisNVS | $273.1B | $143.11 | -0.12% | Switzerland |
| 6 | AstrazenecaAZN | $246.2B | $158.78 | -0.84% | United Kingdom |
| 7 | Abbott LaboratoriesABT | $170.4B | $98.49 | -0.24% | United States |
| 8 | Novo Nordisk A SNVO | $169.1B | $38.18 | -0.21% | Denmark |
| 9 | PfizerPFE | $158.6B | $27.82 | -0.64% | United States |
| 10 | Vertex PharmaceuticalsVRTX | $127.6B | $503.25 | -0.47% | United States |
| 11 | Bristol Myers SquibbBMY | $121.7B | $59.58 | -0.20% | United States |
| 12 | SanofiSNY | $98.1B | $40.23 | +0.07% | France |
| 13 | GSKGSK | $94.1B | $46.54 | -1.02% | United Kingdom |
| 14 | Regeneron PharmaceuticalsREGN | $76.1B | $739.57 | -0.34% | United States |
| 15 | Takeda PharmaceuticalTAK | $58.5B | $18.52 | +0.82% | Japan |
| 16 | Teva Pharmaceutical IndustriesTEVA | $45.7B | $39.25 | +0.18% | Israel |
| 17 | BeOne MedicinesONC | $39.8B | $350.13 | -3.82% | Cayman Islands |
| 18 | Royalty PharmaRPRX | $32.3B | $56.21 | -0.97% | United States |
| 19 | ZoetisZTS | $30.2B | $73.08 | +2.14% | United States |
| 20 | Alnylam PharmaceuticalsALNY | $30.0B | $224.53 | +0.05% | United States |
| 21 | Roivant SciencesROIV | $24.7B | $34.21 | -1.55% | United Kingdom |
| 22 | United TherapeuticsUTHR | $22.9B | $532.78 | -2.24% | United States |
| 23 | InsmedINSM | $21.9B | $100.48 | -1.24% | United States |
| 24 | ViatrisVTRS | $20.0B | $17.44 | -0.29% | United States |
| 25 | Ascendis Pharma A/SASND | $14.7B | $222.69 | -2.50% | Denmark |
| 26 | Jazz PharmaceuticalsJAZZ | $14.4B | $222.45 | -3.78% | Ireland |
| 27 | Summit TherapeuticsSMMT | $13.7B | $17.17 | -4.34% | United States |
| 28 | Corcept TherapeuticsCORT | $12.8B | $118.54 | -0.89% | United States |
| 29 | BridgeBio PharmaBBIO | $12.7B | $65.04 | -2.19% | United States |
| 30 | Elanco Animal HealthELAN | $11.3B | $22.54 | +0.80% | United States |
| 31 | Madrigal PharmaceuticalsMDGL | $11.0B | $476.91 | -2.22% | United States |
| 32 | Biomarin PharmaceuticalBMRN | $10.6B | $54.89 | -0.56% | United States |
| 33 | Dr Reddys LaboratoriesRDY | $10.2B | $12.20 | -0.57% | India |
| 34 | Protagonist TherapeuticsPTGX | $9.05B | $139.91 | -0.72% | United States |
| 35 | Axsome TherapeuticsAXSM | $8.91B | $170.08 | -1.67% | United States |
| 36 | CytokineticsCYTK | $8.62B | $62.01 | +1.46% | United States |
| 37 | Arrowhead PharmaceuticalsARWR | $8.58B | $60.74 | -1.20% | United States |
| 38 | Tg TherapeuticsTGTX | $8.16B | $53.34 | +0.74% | United States |
| 39 | AbivaxABVX | $7.77B | $89.05 | +2.35% | France |
| 40 | Praxis Precision MedicinesPRAX | $7.36B | $263.55 | -5.21% | United States |
| 41 | Ionis PharmaceuticalsIONS | $7.20B | $43.30 | -1.95% | United States |
| 42 | Spyre TherapeuticsSYRE | $7.05B | $79.90 | -1.18% | United States |
| 43 | Amneal PharmaceuticalsAMRX | $6.84B | $19.65 | +0.00% | United States |
| 44 | AlkermesALKS | $6.73B | $40.11 | -3.22% | Ireland |
| 45 | Rhythm PharmaceuticalsRYTM | $6.17B | $89.64 | +1.34% | United States |
| 46 | Kiniksa Pharmaceuticals InternationalKNSA | $6.14B | $78.75 | +1.01% | United States |
| 47 | Belite BioBLTE | $6.14B | $152.52 | -2.28% | United States |
| 48 | Ligand PharmaceuticalsLGND | $5.88B | $295.00 | +0.59% | United States |
| 49 | ErascaERAS | $5.41B | $15.46 | +9.49% | United States |
| 50 | VeradermicsMANE | $5.29B | $126.63 | +14.13% | United States |
| 51 | Mirum PharmaceuticalsMIRM | $5.28B | $81.35 | +0.88% | United States |
| 52 | Ptc TherapeuticsPTCT | $5.22B | $62.56 | -1.06% | United States |
| 53 | Cogent BiosciencesCOGT | $5.22B | $30.08 | -0.20% | United States |
| 54 | GrifolsGRFS | $5.09B | $7.41 | -1.20% | Spain |
| 55 | Travere TherapeuticsTVTX | $4.91B | $52.04 | -2.62% | United States |
| 56 | Genmab A/SGMAB | $4.63B | $36.05 | -1.64% | Denmark |
| 57 | Dianthus TherapeuticsDNTH | $4.61B | $82.43 | -2.89% | United States |
| 58 | Edgewise TherapeuticsEWTX | $4.26B | $39.23 | -0.86% | United States |
| 59 | Indivior PharmaceuticalsINDV | $4.18B | $35.45 | -1.88% | United Kingdom |
| 60 | AbCellera BiologicsABCL | $3.89B | $12.02 | -6.31% | Canada |
| 61 | Tango TherapeuticsTNGX | $3.81B | $22.57 | +3.39% | United States |
| 62 | Telix PharmaceuticalsTLX | $3.73B | $11.01 | -0.99% | Australia |
| 63 | Legend BiotechLEGN | $3.64B | $18.71 | -2.14% | United States |
| 64 | Organon & Co.OGN | $3.61B | $13.75 | -0.29% | United States |
| 65 | Xenon PharmaceuticalsXENE | $3.50B | $36.16 | -0.69% | Canada |
| 66 | Viking TherapeuticsVKTX | $3.49B | $27.73 | -2.84% | United States |
| 67 | IDEAYA BiosciencesIDYA | $3.48B | $36.06 | -0.55% | United States |
| 68 | Parabilis MedicinesPBLS | $3.43B | $28.09 | -2.53% | United States |
| 69 | Amylyx PharmaceuticalsAMLX | $3.41B | $27.20 | -0.84% | United States |
| 70 | Acadia PharmaceuticalsACAD | $3.37B | $19.58 | -0.36% | United States |
| 71 | Arcutis BiotherapeuticsARQT | $3.08B | $24.49 | +1.32% | United States |
| 72 | Dyne TherapeuticsDYN | $3.06B | $16.37 | +2.50% | United States |
| 73 | Arcus BiosciencesRCUS | $3.03B | $23.83 | -2.81% | United States |
| 74 | Enliven TherapeuticsELVN | $2.98B | $40.63 | -1.76% | United States |
| 75 | Zai LabZLAB | $2.79B | $24.81 | -1.98% | China |
| 76 | PrecigenPGEN | $2.72B | $7.60 | +0.80% | United States |
| 77 | MBX BiosciencesMBX | $2.56B | $53.25 | -2.37% | United States |
| 78 | NewAmsterdam PharmaNAMS | $2.54B | $21.26 | -3.93% | Netherlands |
| 79 | LiquidiaLQDA | $2.51B | $28.02 | +5.02% | United States |
| 80 | Vicore Pharma Holding ABVCRE | $2.48B | $8.82 | +1.85% | Sweden |
| 81 | Supernus PharmaceuticalsSUPN | $2.45B | $42.14 | -2.11% | United States |
| 82 | HUTCHMED (China)HCM | $2.38B | $13.67 | -4.27% | Hong Kong |
| 83 | Disc MedicineIRON | $2.33B | $60.77 | -0.67% | United States |
| 84 | Harmony BiosciencesHRMY | $2.31B | $39.60 | +0.66% | United States |
| 85 | Nurix TherapeuticsNRIX | $2.30B | $22.21 | -2.29% | United States |
| 86 | ImmunomeIMNM | $2.28B | $19.31 | +1.13% | United States |
| 87 | SELLAS Life Sciences GroupSLS | $2.27B | $11.26 | -0.44% | United States |
| 88 | Prestige Consumer HealthcarePBH | $2.27B | $47.87 | +0.63% | United States |
| 89 | Bausch Health CompaniesBHC | $2.26B | $6.04 | -1.79% | Canada |
| 90 | PharvarisPHVS | $2.17B | $31.12 | -1.77% | Netherlands |
| 91 | Aurinia PharmaceuticalsAUPH | $2.16B | $16.22 | +1.31% | Canada |
| 92 | Vera TherapeuticsVERA | $2.14B | $29.73 | -1.72% | United States |
| 93 | Viridian TherapeuticsVRDN | $2.08B | $18.34 | +0.33% | United States |
| 94 | PERRIGOPRGO | $2.01B | $14.50 | -0.34% | United States |
| 95 | Mineralys TherapeuticsMLYS | $1.98B | $22.38 | +1.31% | United States |
| 96 | SchrodingerSDGR | $1.97B | $26.39 | -3.30% | United States |
| 97 | Lakefront BiotherapeuticsLKFT | $1.94B | $29.51 | -1.63% | Belgium |
| 98 | Sarepta TherapeuticsSRPT | $1.92B | $18.21 | +4.06% | United States |
| 99 | Agios PharmaceuticalsAGIO | $1.91B | $31.92 | +0.41% | United States |
| 100 | Palvella TherapeuticsPVLA | $1.89B | $131.34 | +0.57% | United States |
Showing 1โ100 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 10 Oct 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 232Computer Manufacturing 10Major Banks 245Industrial Machinery/Components 211Catalog/Specialty Distribution 30Business Services 93Commercial Banks 35Auto Manufacturing 29Integrated oil Companies 16Oil & Gas Production 116Investment Bankers/Brokers/Service 68Department/Specialty Retail Stores 13Real Estate Investment Trusts 175Telecommunications Equipment 84Beverages (Production/Distribution) 36Electronic Components 21Electric Utilities: Central 61Finance: Consumer Services 165Consumer Electronics/Appliances 23Biotechnology: Biological Products (No Diagnostic Substances) 160Medical Specialities 44Property-Casualty Insurers 68All industries โ
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.